Rectal cancer

Gastrointestinal Oncology: A Practical Guide

Volumn , Issue , 2011, Pages 379-421

  Rödel, Claus ^a   Arnold, Dirk ^b   Liersch, Torsten ^c  

^a GOETHE UNIVERSITY   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862837882     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-642-13306-0_13     Document Type: Chapter

References (102)

1. Aschele C et al (2009) Preoperative fuorouracil (FU)-based chemoradiation with and without weekly oxaliplatin in locally advanced rectal cancer: pathologic response analysis of the Studio Terapia Adiuvante Retto (STAR)-01 randomized phase III trial. J Clin Oncol (Meeting Abstracts) 27(18S):CRA4008
2. Barbaro B et al (2009) Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy. Radiology 250(3):730-739
3. Beets-Tan RG, Beets GL (2008) Preoperative staging of rectal tumors: what is the most optimal staging method? Onkologie 31(5):222-223
4. Bertolini F et al (2009) Neoadjuvant treatment with single-agent cetuximab followed by 5-FU, cetuximab, and pelvic radiotherapy: a phase II study in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 73(2):466-472
5. Bipat S et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232(3):773-783
6. Birgisson H et al (2005) Occurrence of second cancers in patients treated with radiotherapy for rectal cancer. J Clin Oncol 23(25):6126-6131
7. Borschitz T et al (2008) Neoadjuvant chemoradiation and local excision for T2-3 rectal cancer. Ann Surg Oncol 15(3):712-720
8. Bosset JF et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114-1123
9. Braendengen M et al (2008) Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 26(22):3687-3694
10. Bujko K et al (2004) Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 72(1):15-24
11. Bujko K et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93(10):1215-1223
12. Cafero F et al (2003) Randomized clinical trial of adjuvant postoperative RT vs. sequential postoperative ER plus 5-FU and levamisol in patients with stage II-III resectable rectal cancer: a fnal report. J Surg Oncol 83(3):140-146
13. Calvo FA et al (2004) 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int J Radiat Oncol Biol Phys 58(2):528-535
14. Calvo FA et al (2006) Improved incidence of pT0 downstaged surgical specimens in locally advanced rectal cancer (LARC) treated with induction oxaliplatin plus 5-fuorouracil and pre-operative chemoradiation. Ann Oncol 17(7):1103-1110
15. Camma C et al (2000) Preoperative radiotherapy for resectable rectal cancer: a meta-analysis. JAMA 284(8):1008-1015
16. Capirci C et al (2008) Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients. Int J Radiat Oncol Biol Phys 72(1):99-107
17. Cavaliere F et al (1995) Coloanal anastomosis for rectal cancer. Long-term results at the Mayo and Cleveland Clinics. Dis Colon Rectum 38(8):807-812
18. Ceelen W et al (2009) Preoperative chemoradiation versus radiation alone for stage II and III resectable rectal cancer: a systematic review and meta-analysis. Int J Cancer 124(12): 2966-2972
19. Chau I et al (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemora-diation and total mesorectal excision in magnetic resonance imaging-defned poor-risk rectal cancer. J Clin Oncol 24(4):668-674
20. Cho E et al (2004) Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studies. Ann Intern Med 140(8):603-613
21. Collette L et al (2007) Patients with curative resection of cT3-4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody beneft from adjuvant fuorouracil-based chemotherapy? A trial of the European Organisation for Research and Treatment of Cancer Radiation Oncology Group. J Clin Oncol 25(28):4379-4386
22. Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomised trials. Lancet 358(9290): 1291-1304
23. Crane CH et al (2010) Phase II Trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 76(3): 824-830
24. Debucquoy A et al (2009) Molecular response to cetuximab and effcacy of preoperative cetuximab-based chemoradiation in rectal cancer. J Clin Oncol 27(17):2751-2757
25. den Dulk M et al (2009) Multicentre analysis of oncological and survival outcomes following anastomotic leakage after rectal cancer surgery. Br J Surg 96(9):1066-1075
26. DiPetrillo TA et al (2008) Neoadjuvant bevacizumab, oxaliplatin, 5-fuorouracil, and radiation in clinical stage II-III rectal cancer. J Clin Oncol 26:Abstract 15041
27. Frykholm GJ, Glimelius B, Pahlman L (1993) Preoperative or postoperative irradiation in adeno-carcinoma of the rectum: fnal treatment results of a randomized trial and an evaluation of late secondary effects. Dis Colon Rectum 36(6):564-572
28. Gastrointestinal Tumor Study Group (1985) Prolongation of the disease-free interval in surgically treated rectal carcinoma. N Engl J Med 312(23):1465-1472
29. Gastrointestinal Tumor Study Group (1992) Radiation therapy and fuorouracil with or without semustine for the treatment of patients with surgical adjuvant adenocarcinoma of the rectum. J Clin Oncol 10(4):549-557
30. Gerard JP et al (2006) Preoperative radiotherapy with or without concurrent fuorouracil and leu-covorin in T3-4 rectal cancers: results of FFCD 9203. J Clin Oncol 24(28):4620-4625
31. Gerard J et al (2009) Randomized multicenter phase III trial comparing two neoadjuvant chemo-radiotherapy (CT-RT) regimens (RT45-Cap versus RT50-Capox) in patients (pts) with locally advanced rectal cancer (LARC): Results of the ACCORD 12/0405 PRODIGE 2. J Clin Oncol (Meeting Abstracts) 27(18S):LBA4007
32. Glimelius B et al (2003) A systematic overview of radiation therapy effects in rectal cancer. Acta Oncol 42(5-6):476-492
33. Glynne-Jones R, Anyemene N (2009) Histologic response grading after chemoradiation in locally advanced rectal cancer: a proposal for standardized reporting. Int J Radiat Oncol Biol Phys 73(4):971-973
34. Glynne-Jones R et al (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 94(3):363-371
35. Grady WM, Carethers JM (2008) Genomic and epigenetic instability in colorectal cancer patho-genesis. Gastroenterology 135(4):1079-1099
36. Greene FL, Stewart AK, Norton HJ (2004) New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol 22(10):1778-1784
37. Guerrieri M et al (2008) Transanal endoscopic microsurgery for the treatment of selected patients with distal rectal cancer: 15 years experience. Surg Endosc 22(9):2030-2035
38. Gunderson LL et al (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22(10):1785-1796
39. Habr-Gama A, Perez RO (2009) Non-operative management of rectal cancer after neoadjuvant chemoradiation. Br J Surg 96(2):125-127
40. Heald RJ, Ryall RD (1986) Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1(8496):1479-1482
41. Hermanek P et al (2003) The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis 18(4):335-341
42. Holm T et al (2007) Extended abdominoperineal resection with gluteus maximus fap reconstruction of the pelvic foor for rectal cancer. Br J Surg 94(2):232-238
43. Horisberger K et al (2009) Cetuximab in combination with capecitabine, irinotecan, and radiotherapy for patients with locally advanced rectal cancer: results of a Phase II MARGIT trial. Int J Radiat Oncol Biol Phys 74(5):1487-1493
44. Huerta S (2008) Recent advances in the molecular diagnosis and prognosis of colorectal cancer. Expert Rev Mol Diagn 8(3):277-288
45. Ishiguro S et al (2009) Pelvic exenteration for clinical T4 rectal cancer: oncologic outcome in 93 patients at a single institution over a 30-year period. Surgery 145(2):189-195
46. Jemal A et al (2009) Cancer statistics. CA Cancer J Clin 59(4):225-249
47. Kalofonos HP et al (2008) A randomised phase III trial of adjuvant radio-chemotherapy comparing Irinotecan, 5FU and Leucovorin to 5FU and Leucovorin in patients with rectal cancer: a Hellenic Cooperative Oncology Group Study. Eur J Cancer 44(12):1693-1700
48. Kapiteijn E et al (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345(9):638-646
49. Krook JE et al (1991) Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 324(11):709-715
50. Lahaye MJ et al (2008) USPIO-enhanced MR imaging for nodal staging in patients with primary rectal cancer: predictive criteria. Radiology 246(3):804-811
51. Langer C et al (2003) Surgical cure for early rectal carcinoma and large adenoma: transanal endo-scopic microsurgery (using ultrasound or electrosurgery) compared to conventional local and radical resection. Int J Colorectal Dis 18(3):222-229
52. Lashner BA et al (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112(1):29-32
53. Law WL et al (2007) Anastomotic leakage is associated with poor long-term outcome in patients after curative colorectal resection for malignancy. J Gastrointest Surg 11(1):8-15
54. Learn PA, Kahlenberg MS (2009) Hereditary colorectal cancer syndromes and the role of the surgical oncologist. Surg Oncol Clin N Am 18(1):121-144, ix
55. Leslie A et al (2002) The colorectal adenoma-carcinoma sequence. Br J Surg 89(7):845-860
56. Lezoche G et al (2008) A prospective randomized study with a 5-year minimum follow-up evaluation of transanal endoscopic microsurgery versus laparoscopic total mesorectal excision after neoadjuvant therapy. Surg Endosc 22(2):352-358
57. Lopez-Kostner F et al (1998) Total mesorectal excision is not necessary for cancers of the upper rectum. Surgery 124(4):612-617; discussion 617-618
58. Machiels JP et al (2007) Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann Oncol 18(4):738-744
59. Marijnen CA et al (2008) Preoperative chemoradiotherapy regimen with capecitabine and bevaci-zumab in locally advanced rectal cancer: a feasibility study of the Dutch Colorectal Cancer Group (DCCG). J Clin Oncol 26:Abstract 15040
60. Marquardt F et al (2009) Molecular targeted treatment and radiation therapy for rectal cancer. Strahlenther Onkol 185(6):371-378
61. Martling A et al (2002) The surgeon as a prognostic factor after the introduction of total mesorectal excision in the treatment of rectal cancer. Br J Surg 89(8):1008-1013
62. Matthiessen P et al (2007) Defunctioning stoma reduces symptomatic anastomotic leakage after low anterior resection of the rectum for cancer: a randomized multicenter trial. Ann Surg 246(2):207-214
63. MERCURY Study Group (2007) Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 243(1):132-139
64. Minsky BD et al (1992) Enhancement of radiation-induced downstaging of rectal cancer by fuo-rouracil and high-dose leucovorin chemotherapy. J Clin Oncol 10(1):79-84
65. Moriya Y et al (2003) Aggressive surgical treatment for patients with T4 rectal cancer. Colorectal Dis 5(5):427-431
66. Nagtegaal ID, Quirke P (2008) What is the role for the circumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26(2):303-312
67. Nagtegaal ID et al (2005) Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 23(36):9257-9264
68. NIH consensus conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264(11):1444-1450
69. Nivatvongs S (2000) Surgical management of early colorectal cancer. World J Surg 24:1052-1055
70. Norat T et al (2005) Meat, fsh, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 97(12):906-916
71. O'Connell MJ et al (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fuorouracil with radiation therapy after curative surgery. N Engl J Med 331(8): 502-507
72. Peeters KC et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival beneft in irradiated patients with resectable rectal carcinoma. Ann Surg 246(5):693-701
73. Puli SR et al (2009) Accuracy of endoscopic ultrasound to diagnose nodal invasion by rectal cancers: a meta-analysis and systematic review. Ann Surg Oncol 16(5):1255-1265
74. Quirke P et al (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision. Lancet 2(8514):996-999
75. Quirke P et al (2007) The future of the TNM staging system in colorectal cancer: time for a debate? Lancet Oncol 8(7):651-657
76. Quirke P et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 373(9666):821-828
77. Radu C et al (2008) Short-course preoperative radiotherapy with delayed surgery in rectal cancer-a retrospective study. Radiother Oncol 87(3):343-349
78. Rodel C, Sauer R (2007) Integration of novel agents into combined-modality treatment for rectal cancer patients. Strahlenther Onkol 183(5):227-235
79. Rodel C et al (2007) Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer. J Clin Oncol 25(1):110-117
80. Rodel C et al (2008) Phase I-II trial of cetuximab, capecitabine, oxaliplatin, and radiotherapy as preoperative treatment in rectal cancer. Int J Radiat Oncol Biol Phys 70(4):1081-1086
81. Rödel C et al (2005) Prognostic signifcance of tumor regression after preoperative chemoradio-therapy for rectal cancer. J Clin Oncol 23(34):8688-8696
82. Roh MS et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27(31):5124-5130
83. Rutten HJ et al (2008) Controversies of total mesorectal excision for rectal cancer in elderly patients. Lancet Oncol 9(5):494-501
84. Sauer R et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351(17):1731-1740
85. Sebag-Montefore D et al (2009) Preoperative radiotherapy versus selective postoperative chemo-radiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373(9666):811-820
86. Smalley SR et al (2006) Phase III trial of fuorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24(22):3542-3547
87. Sterk P et al (2000) Vascular organization in the mesorectum: angiography of rectal resection specimens. Int J Colorectal Dis 15(4):225-228
88. Swedish Rectal Cancer Trial (1997) Improved survival with preoperative radiotherapy in resect-able rectal cancer. N Engl J Med 336(14):980-987
89. Tepper JE et al (2002) Adjuvant therapy in rectal cancer: analysis of stage, sex, and local controlfnal report of intergroup 0114. J Clin Oncol 20(7):1744-1750
90. Tveit KM et al (1997) Randomized controlled trial of postoperative radiotherapy and short-term time-scheduled 5-fuorouracil against surgery alone in the treatment of Dukes B and C rectal cancer. Norwegian Adjuvant Rectal Cancer Project Group. Br J Surg 84(8):1130-1135
91. Valentini V et al (2008) Evidence and research in rectal cancer. Radiother Oncol 87(3):449-474
92. Valentini V et al (2009) Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2). Radiother Oncol 92(2):148-163
93. Watanabe T et al (2008) Lateral pelvic lymph node dissection or chemoradiotherapy: which is the procedure of choice to reduce local recurrence rate in lower rectal cancer? Ann Surg 248(2): 342-343; author reply 343
94. West NP et al (2008) Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 26(21):3517-3522
95. Whittemore AS et al (1990) Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst 82(11):915-926
96. Willett CG et al (2004) Direct evidence that the VEGF-specifc antibody bevacizumab has antivas-cular effects in human rectal cancer. Nat Med 10(2):145-147
97. Willett CG et al (2009) Effcacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fuorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol 27(18):3020-3026
98. Williams CS, Mann M, DuBois RN (1999) The role of cyclooxygenases in infammation, cancer, and development. Oncogene 18(55):7908-7916
99. Wittekind Ch, Henson DE, Hutter RVP, Sobin LH (eds) (2001) TNM supplement. A commentary on uniform use, 2nd edn. Wiley, New York
100. Wolmark N et al (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92(5):388-396
101. Yamada K et al (2002) Pelvic exenteration and sacral resection for locally advanced primary and recurrent rectal cancer. Dis Colon Rectum 45(8):1078-1084
102. Yee J (2009) CT colonography: techniques and applications. Radiol Clin North Am 47(1):133-145